Bangladesh has long been the largest source of medical tourists to India, with a 48 per cent year-on-year (Y-o-Y) surge bringing 449,570 patients in 2023 alone
The ICMR and Panacea Biotec have initiated the first-ever phase three clinical trial for developing a dengue vaccine in India, the Union Health Ministry said on Wednesday. India's indigenous tetravalent dengue vaccine, DengiAll, has been developed by Panacea Biotec and the first participant in this trial was vaccinated on Wednesday at the Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences, Rohtak. The phase three clinical trial will be conducted across 19 sites in 18 states and union territories, involving more than 10,335 healthy adult participants. "The initiation of this phase three clinical trial for India's first indigenous dengue vaccine marks a critical advancement in our fight against dengue. It reflects our commitment to protecting our citizens from this pervasive disease and underscores India's capabilities in vaccine research and development," Union Health Minister J P Nadda said. "Through this collaboration between ICMR and Panacea Biotec, we are no
The company reported 9 per cent on-year increase in its average revenue per occupied bed (Arpob) at Rs 30,551 in Q1FY25, with bed occupancy rising to 61 per cent in Q1 from 51 per cent last year
In various healthcare companies covering hospitals, pharmaceuticals, life sciences, medical devices, among others
The survey on health will build upon the 79th round of the NSS, which had covered only a few topics on health, in contrast to the latest round, which is expected to be more extensive
The company claims this test will be priced between Rs 15,000 and 20,000, making it more affordable than the current market options, which range from Rs 30,000 to 40,000
A separate marketing practices code has been a long-standing demand for medical devices. Currently, the industry has to comply with the marketing practices code for pharmaceuticals
"Seasonality-driven molecules and molecular combinations, especially anti-infectives, have shown a relatively stronger volume-driven growth," the firm stated in its report
The company's revenue from operations rose to Rs 1,859 crore in Q1FY25, a 12.2 per cent Y-o-Y rise from Rs 1,657 crore reported in Q1FY24
The lesser numbers in Telangana are due to the presence of the state's own health insurance scheme for the poor, 'Aarogyasri,' which later merged with AB-PMJAY only in 2021
Max to invest Rs 230 crore to set up 250 bed hospital in Mohali
5 of 12 CoEs formed to treat rare diseases have spent less than 35% funds allotted
Even as experts acknowledge the challenge, they also point to a rising trend in the number of psychiatrists due to an increased number of postgraduate seats in recent years
The study found that the decline was more pronounced among females (3.1 years) compared to males (2.1 years)
As American biopharma looks to diversify sourcing, Indian companies stand to benefit
The Budget Session of Parliament will commence on July 22 and subject to exigencies of Government Business, the session may conclude on August 12
Experts said as India falls on the one of main pathways that migratory birds take to move between continents, its water bodies are always prone to the spread of influenza from birds
Bumper RBI dividend may help govt increase funding
Indian startups and researchers have over the years worked on the technology to build practical solutions
It also announced that the facility for uploading the certificate by advertisers/advertising agencies for TV and radio ads has been made operational on the Broadcast Seva Portal